Joanne is currently in treatment after receiving a second breast cancer diagnosis. She reflects on the resources she found helpful after her first diagnosis, especially those she used after her treatment finished.
Researchers based at the Royal College of Surgeons in Ireland have discovered changes in secondary breast cancer that has spread to the brain, which could make the disease vulnerable to drugs called PARP inhibitors.
Last July, we launched our Time For Trodelvy campaign to ensure that all eligible patients could access Trodelvy, an exciting new drug that could give certain women living with triple negative secondary breast cancer the hope of more time.
When Clare was told she had breast cancer and needed a mastectomy, she expected to be upset by it. After approaching her treatment with positivity, however, she now feels better than she ever did before.